Nanotechnology is not sexy anymore and we have a new hype! It looks like stem cell treatment is regarded as panacea! Everything is potentially treatable with stem cells!
From the advertisement of one review:
With our study you also assess the R&D pipeline, seeing trends and outlooks. You find discussions of treatments in development, by therapeutic area and organisation:
• Autoimmune diseases - modifying the immune system
• Diabetes - restoring pancreatic function
• Oncology and cancer treatment
• Cardiovascular diseases - healing the heart and vascular system
• Neurological and cerebrovascular disorders - regenerating CNS tissue
• Ophthalmic disorders - potential for overcoming sight loss
• Bioartificial livers and hepatic regeneration with stem and progenitor cells
• Dermatology - developments in cellular skin repair
• Adipose-derived stem cells for autologous treatments
• Regenerative dentistry - potential for biotechnological tooth replacement.
What will happen next? The biotechnology industry will develop many products using stem cells and increase revenues there from 2012 to 2022. The R&D pipeline is extensive. Overall world revenue will reach $7.3bn in 2014, our report forecasts.
Expansion of the market will result from new stem cell treatments and increased uptake of those technologies in drug development assays.
A diverse pipeline of therapies offers hope for treating many diseases. There are potential cures for diabetes, HIV and dry age-related macular degeneration (AMD).
Stem cell-based innovations tackle cardiovascular disorders, autoimmune diseases, metabolic disorders and many other conditions. Some of the breakthroughs will be a commercial reality by 2022, our investigation predicts.
No comments:
Post a Comment